Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy
AIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2013-06-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31283 |
_version_ | 1818524371716669440 |
---|---|
author | F U Dzgoeva T M Gatagonova Z K Kadzaeva O V Khamitsaeva Z Kh Kochisova A T Dzutseva B G Bazaeva T L Bestaeva |
author_facet | F U Dzgoeva T M Gatagonova Z K Kadzaeva O V Khamitsaeva Z Kh Kochisova A T Dzutseva B G Bazaeva T L Bestaeva |
author_sort | F U Dzgoeva |
collection | DOAJ |
description | AIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged 22 to 63 years with ESRF were examined. The follow-up was 18 months. LV ejection fraction, peak early diastolic filling rate, peak late diastolic filling rate, their ratio, LV isovolumic relaxation time, LV end-diastolic diameter, LV end-diastolic volume, LV end-diastolic diameter index (EDDI), LV posterior wall and ventricular septal thickness, and LV mass index were determined. J. Gottdiener's classification based on the calculation of EDDI and LV relative wall thickness was used to estimate LV geometry. Erythropoietin was given to patients with the baseline level of hemoglobin (Hb) |
first_indexed | 2024-12-11T05:56:10Z |
format | Article |
id | doaj.art-4b773c08497f4a86985f7b2eb4f9d5d9 |
institution | Directory Open Access Journal |
issn | 0040-3660 2309-5342 |
language | Russian |
last_indexed | 2024-12-11T05:56:10Z |
publishDate | 2013-06-01 |
publisher | "Consilium Medicum" Publishing house |
record_format | Article |
series | Терапевтический архив |
spelling | doaj.art-4b773c08497f4a86985f7b2eb4f9d5d92022-12-22T01:18:40Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422013-06-01856445028299Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapyF U DzgoevaT M GatagonovaZ K KadzaevaO V KhamitsaevaZ Kh KochisovaA T DzutsevaB G BazaevaT L BestaevaAIM: To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin/MATERIAL AND METHODS: 107 patients (57 women and 50 men) aged 22 to 63 years with ESRF were examined. The follow-up was 18 months. LV ejection fraction, peak early diastolic filling rate, peak late diastolic filling rate, their ratio, LV isovolumic relaxation time, LV end-diastolic diameter, LV end-diastolic volume, LV end-diastolic diameter index (EDDI), LV posterior wall and ventricular septal thickness, and LV mass index were determined. J. Gottdiener's classification based on the calculation of EDDI and LV relative wall thickness was used to estimate LV geometry. Erythropoietin was given to patients with the baseline level of hemoglobin (Hb)https://ter-arkhiv.ru/0040-3660/article/view/31283end-stage renal failurediastolic dysfunctionleft ventricular hypertrophyanemiaerythropoietin |
spellingShingle | F U Dzgoeva T M Gatagonova Z K Kadzaeva O V Khamitsaeva Z Kh Kochisova A T Dzutseva B G Bazaeva T L Bestaeva Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy Терапевтический архив end-stage renal failure diastolic dysfunction left ventricular hypertrophy anemia erythropoietin |
title | Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy |
title_full | Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy |
title_fullStr | Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy |
title_full_unstemmed | Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy |
title_short | Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy |
title_sort | diastolic dysfunction in different types of left ventricular hypertrophy in patients with end stage renal failure impact of long term erythropoietin therapy |
topic | end-stage renal failure diastolic dysfunction left ventricular hypertrophy anemia erythropoietin |
url | https://ter-arkhiv.ru/0040-3660/article/view/31283 |
work_keys_str_mv | AT fudzgoeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT tmgatagonova diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT zkkadzaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT ovkhamitsaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT zkhkochisova diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT atdzutseva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT bgbazaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy AT tlbestaeva diastolicdysfunctionindifferenttypesofleftventricularhypertrophyinpatientswithendstagerenalfailureimpactoflongtermerythropoietintherapy |